Evidence map›Paper›PMID 22904278›Full record

ArticleJournal of bacteriology2012

Undecaprenyl pyrophosphate involvement in susceptibility of Bacillus subtilis to rare earth elements.

Takashi Inaoka, Kozo Ochi

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Engineering of Multiple Modules to Improve Amorphadiene Production inJournal of agricultural and food chemistry · 2021
    Article
  5. Accumulation and Release of Rare Earth Ions by Spores ofApplied and environmental microbiology · 2019
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Takashi InaokaNational Food Research Institute-National Agriculture Research Organization, Tsukuba, Ibaraki, Japan. tina2672@affrc.go.jp
Kozo Ochi
Food Research Institute · JPHiroshima Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rare earth element scandium has weak antibacterial potency. We identified a mutation responsible for a scandium-resistant phenotype in Bacillus subtilis. This mutation was found within the uppS gene, which encodes undecaprenyl pyrophosphate synthase, and designated uppS86 (for the Thr-to-Ile amino acid substitution at residue 86 of undecaprenyl pyrophosphate synthase). The uppS86 mutation also gave rise to increased resistance to bacitracin, which prevents cell wall synthesis by inhibiting the dephosphorylation of undecaprenyl pyrophosphate, in addition to enhanced amylase production. Conversely, overexpression of the wild-type uppS gene resulted in increased susceptibilities to both scandium and bacitracin. Moreover, the mutant lacking undecaprenyl pyrophosphate phosphatase (BcrC) showed increased susceptibility to all rare earth elements tested. These results suggest that the accumulation of undecaprenyl pyrophosphate renders cells more susceptible to rare earth elements. The availability of undecaprenyl pyrophosphate may be an important determinant for susceptibility to rare earth elements, such as scandium.

Indexed as

Alkyl and Aryl TransferasesAnti-Bacterial AgentsBacillus subtilisBacitracinDrug Resistance, BacterialGene DosageGene ExpressionMicrobial Sensitivity TestsMutant ProteinsMutation, MissensePolyisoprenyl PhosphatesScandiumAlkyl and Aryl TransferasesAnti-Bacterial AgentsBacitracinMutant ProteinsPolyisoprenyl PhosphatesScandiumundecaprenyl pyrophosphateundecaprenyl pyrophosphate synthetase

Identifiers

PMID22904278
PMCPMC3458658
OpenAlexW2160083844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.